UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection

BMC gastroenterology, 2012-05, Vol.12 (1), p.43-43, Article 43

2012

Volltextzugriff (PDF)

Genotype B and Younger Patient Age Associated with Better Response to Low-Dose Therapy: A Trial with Pegylated/Nonpegylated Interferon-α-2b for Hepatitis B e Antigen—Positive Patients with Chronic Hepatitis B in China

Clinical infectious diseases, 2007-02, Vol.44 (4), p.541-548

2007

Volltextzugriff (PDF)

Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells

World journal of gastroenterology : WJG, 2010-02, Vol.16 (5), p.618-624

2010

Volltextzugriff (PDF)

Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B

World journal of gastroenterology : WJG, 2005-05, Vol.11 (19), p.2892

2005

Volltextzugriff (PDF)

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial

World journal of gastroenterology : WJG, 2003-11, Vol.9 (11), p.2480

2003

Volltextzugriff (PDF)

Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon

Theranostics, 2015, Vol.5 (3), p.218-226

2015

Volltextzugriff (PDF)

Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy

Journal of hepatology, 2009-05, Vol.50 (5), p.895-905

2009

Volltextzugriff (PDF)

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study

World journal of gastroenterology : WJG, 2004-11, Vol.10 (22), p.3269

2004

Volltextzugriff (PDF)

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters

World journal of gastroenterology : WJG, 2003-11, Vol.9 (11), p.2574

2003

Volltextzugriff (PDF)

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

Hepatology (Baltimore, Md.), 2005-12, Vol.42 (6), p.1437-1445

2005

Volltextzugriff (PDF)

Therapy for chronic hepatitis B: can we reject combination therapy

Zhonghua gan zang bing za zhi, 2012-02, Vol.20 (2), p.86

Wan, Mo-bin

2012

Volltextzugriff (PDF)

Optimal therapy for chronic hepatitis B patients

Zhonghua gan zang bing za zhi, 2011-06, Vol.19 (6), p.402

Wan, Mo-Bin

2011

Volltextzugriff (PDF)

Relationship between clinical and pathologic findings in patients with chronic liver diseases

World journal of gastroenterology : WJG, 2003-12, Vol.9 (12), p.2796

2003

Volltextzugriff (PDF)

The present situation and pondering on antiviral therapy in patients with decompensated cirrhosis

Zhonghua gan zang bing za zhi, 2010-07, Vol.18 (7), p.483

Wan, Mo-Bin

2010

Volltextzugriff (PDF)

Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo

World journal of gastroenterology : WJG, 2004-03, Vol.10 (5), p.664

2004

Volltextzugriff (PDF)

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients

Hepatology international, 2014, Vol.8 (1), p.72-82

2014

Volltextzugriff (PDF)

The importance of personalized optimal therapy for chronic hepatitis B patients

Zhonghua gan zang bing za zhi, 2008-05, Vol.16 (5), p.326

Wan, Mo-bin

2008

Volltextzugriff (PDF)

The study on frequency distribution of regulatory T cells and its functional markers in peripheral blood of chronic hepatitis B

Zhonghua shi yan he lin chuang bing du xue za ji, 2011-02, Vol.25 (1), p.33

2011

Volltextzugriff (PDF)

Mutation incidence of and resistant sites in HBV after long-term nucleoside analogs therapy

Zhonghua gan zang bing za zhi, 2007-01, Vol.15 (1), p.55

2007

Volltextzugriff (PDF)

Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein

Shengwu gongcheng xuebao, 2007-09, Vol.23 (5), p.862

2007

Volltextzugriff (PDF)

Expert recommendations on the application of interferon for chronic hepatitis B

Journal of digestive diseases, 2013-12, Vol.14 (12), p.626-637

2013

Volltextzugriff (PDF)

The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52

Zhonghua gan zang bing za zhi, 2007-05, Vol.15 (5), p.342

2007

Volltextzugriff (PDF)

Coding single nucleotide polymorphism is an ideal marker for detecting gene imprinting by 5' nuclease assay

Zhonghua yi xue yi chuan xue za zhi, 2003-06, Vol.20 (3), p.225

2003

Volltextzugriff (PDF)

Therapeutic and preventive activities of lamivudine on HBV re-activation in HBV carriers with immunodeficiency

Zhonghua gan zang bing za zhi, 2005-05, Vol.13 (5), p.382

2005

Volltextzugriff (PDF)

Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial

Zhonghua gan zang bing za zhi, 2004-10, Vol.12 (10), p.597

2004

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(43)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(21)
Life Sciences & Biomedicine
(17)
Male
(16)
Female
(15)
Middle Aged
(15)
Adult
(14)
Gastroenterology & Hepatology
(12)
Hepatitis B, Chronic - Drug Therapy
(11)
Aged
(8)
Adolescent
(7)
Treatment Outcome
(7)
Antiviral Agents - Therapeutic Use
(6)
Hepatitis B Virus
(6)
Viral Hepatitis
(6)
Alanine Transaminase - Blood
(5)
Animals
(5)
Antiviral Agents - Administration & Dosage
(5)
Chronic Hepatitis B
(5)
Dna, Viral - Blood
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection

Genotype B and Younger Patient Age Associated with Better Response to Low-Dose Therapy: A Trial with Pegylated/Nonpegylated Interferon-α-2b for Hepatitis B e Antigen—Positive Patients with Chronic Hepatitis B in China

Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells

Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial

Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon

Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

Therapy for chronic hepatitis B: can we reject combination therapy

Optimal therapy for chronic hepatitis B patients

Relationship between clinical and pathologic findings in patients with chronic liver diseases

The present situation and pondering on antiviral therapy in patients with decompensated cirrhosis

Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients

The importance of personalized optimal therapy for chronic hepatitis B patients

The study on frequency distribution of regulatory T cells and its functional markers in peripheral blood of chronic hepatitis B

Mutation incidence of and resistant sites in HBV after long-term nucleoside analogs therapy

Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein

Expert recommendations on the application of interferon for chronic hepatitis B

The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52

Coding single nucleotide polymorphism is an ideal marker for detecting gene imprinting by 5' nuclease assay

Therapeutic and preventive activities of lamivudine on HBV re-activation in HBV carriers with immunodeficiency

Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial

Suchergebnisse filtern